Dynavox Group AB (publ) (DYVOX.ST) has a MoatMap StockRank of 33/100 based on Quality (66/100), Value (18/100), and Momentum (36/100) factor scores. The current signal is SELL. Tobii Dynavox is a high-quality, niche monopoly in assistive communication technology with strong ROIC and pricing power. However, it lacks a direct connection to our 18-month macro themes, making it a high-quality compounder rather than an asymmetric macro play.
Dynavox Group AB (Tobii Dynavox) is the global market leader in assistive technology for communication, specializing in Augmentative and Alternative Communication (AAC) devices and eye-tracking software. The company serves individuals with disabilities such as ALS, autism, cerebral palsy, and spinal cord injuries, enabling them to speak and interact. Its competitive moat is built on proprietary eye-tracking technology, a dedicated clinical sales force, and established reimbursement pathways in major healthcare markets.
| Price | $7.88 |
| Market Cap | $931M |
| P/E (TTM) | 45.33 |
| P/E (Forward) | 36.48 |
| Price/Book | 12.35 |
| Return on Equity | 32.5% |
| Return on Invested Capital | 13.9% |
| Debt/Equity | 167.12 |
| Gross Margin | 68.2% |
| Operating Margin | 9.9% |
| Revenue Growth | 1.2% |
| Dividend Yield | 0.7% |
| Free Cash Flow | $372K |
Dynavox Group AB (publ) operates in the Medical Instruments & Supplies industry, part of the Healthcare sector (Sweden).